{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:44:38Z","timestamp":1781181878484,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460250"],"award-info":[{"award-number":["82460250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20202BBG73030"],"award-info":[{"award-number":["20202BBG73030"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20202BABL206078"],"award-info":[{"award-number":["20202BABL206078"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Provincial and Ministerial level Fund","award":["20212BAB216025"],"award-info":[{"award-number":["20212BAB216025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis or occlusion of the internal carotid artery, with an abnormal vascular network forming as compensation. The etiology of MMD remains largely unknown, though genetic and immune factors have been implicated. This study aimed to investigate the landscape of peripheral immune cells in MMD patients using single-cell RNA sequencing (scRNA-seq) to identify potential biomarkers and mechanisms involved in the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral blood mononuclear cells (PBMCs) were collected from six MMD patients and three controls. scRNA-seq was performed to analyze the transcriptomic profiles of various immune cell populations. Differential gene expression, functional enrichment, and cell interaction analyses were conducted to identify significant alterations in immune cell subpopulations. Additionally, trajectory analysis was used to explore the differentiation pathways of monocytes in MMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study identified significant transcriptional alterations in peripheral immune cells, particularly in monocytes and natural killer (NK) cells. Notably, intermediate monocytes (Mono_CD14_CD16) were increased in MMD patients compared to controls. Functional enrichment analysis revealed upregulation of genes related to immune cell activation and signal transduction in MMD. Two previously uncharacterized genes, RETN and TGFBR2, were identified as potential biomarkers. Trajectory analysis suggested that classical monocytes may differentiate into intermediate monocytes in MMD. Cell interaction analysis highlighted the role of Mono_CD14_CD16 cells in mediating immune responses through interactions involving RETN and TGF-\u03b2 signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides a comprehensive analysis of peripheral immune cell alterations in MMD, highlighting the involvement of monocyte subpopulations and specific signaling pathways in disease pathogenesis. The findings offer new insights into the immune dysregulation in MMD and suggest potential targets for diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04241-5","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:37:19Z","timestamp":1770323839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell transcriptomic profiling of peripheral blood mononuclear cells reveals monocyte heterogeneity in patients with Moyamoya disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinlin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingpeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhou","family":"Miu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"4241_CR1","doi-asserted-by":"publisher","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;(2009):1226\u20131237. https:\/\/doi.org\/10.1056\/NEJMra0804622.","DOI":"10.1056\/NEJMra0804622"},{"key":"4241_CR2","doi-asserted-by":"crossref","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;(2008):1056\u20131066. https:\/\/pubmed.ncbi.nlm.nih.gov\/18940695\/.","DOI":"10.1016\/S1474-4422(08)70240-0"},{"key":"4241_CR3","doi-asserted-by":"crossref","unstructured":"Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;(2022):747\u2013758. https:\/\/pubmed.ncbi.nlm.nih.gov\/35605621\/.","DOI":"10.1016\/S1474-4422(22)00165-X"},{"key":"4241_CR4","doi-asserted-by":"publisher","unstructured":"Hayashi T, Akioka N, Kashiwazaki D, Kuwayama N, Kuroda S. Ischemic stroke in pediatric Moyamoya disease associated with immune thrombocytopenia\u2013a case report. Childs Nerv Syst. 2015;(2015):991\u2013996. https:\/\/doi.org\/10.1007\/s00381-015-2619-4.","DOI":"10.1007\/s00381-015-2619-4"},{"key":"4241_CR5","doi-asserted-by":"publisher","unstructured":"Sarkar P, Thirumurugan K. New insights into TNFalpha\/PTP1B and PPARgamma pathway through RNF213- a link between inflammation, obesity, insulin resistance, and Moyamoya disease. Gene. 2021;(2021):145340. https:\/\/doi.org\/10.1016\/j.gene.2020.145340.","DOI":"10.1016\/j.gene.2020.145340"},{"key":"4241_CR6","doi-asserted-by":"publisher","unstructured":"Chen JB, Liu Y, Zhou LX, Sun H, He M, You C. Prevalence of autoimmune disease in Moyamoya disease patients in Western Chinese population. J Neurol Sci. 2015;(2015):184\u2013186. https:\/\/doi.org\/10.1016\/j.jns.2015.02.037.","DOI":"10.1016\/j.jns.2015.02.037"},{"key":"4241_CR7","doi-asserted-by":"publisher","unstructured":"Sigdel TK, Shoemaker LD, Chen R, Li L, Butte AJ, Sarwal MM, Steinberg GK. Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis. 2013;(2013):45. https:\/\/doi.org\/10.1186\/1750-1172-8-45.","DOI":"10.1186\/1750-1172-8-45"},{"key":"4241_CR8","doi-asserted-by":"publisher","unstructured":"Fang YC, Wei LF, Hu CJ, Tu YK. Pathological circulating factors in Moyamoya disease. Int J Mol Sci. 2021;(2021). https:\/\/doi.org\/10.3390\/ijms22041696.","DOI":"10.3390\/ijms22041696"},{"key":"4241_CR9","doi-asserted-by":"publisher","unstructured":"Liu C, Ge P, Zhang B, Chan L, Pang Y, Tao C, Li J, He Q, Liu W, Mou S, Zheng Z, Zhao Z, Sun W, Zhang Q, Wang R, Zhang Y, Wang W, Zhang D, Zhao J. Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease. Immunol Res. 2024;(2024):654\u2013664. https:\/\/doi.org\/10.1007\/s12026-024-09464-x.","DOI":"10.1007\/s12026-024-09464-x"},{"key":"4241_CR10","doi-asserted-by":"publisher","unstructured":"Ge P, Tao C, Wang W, He Q, Liu C, Zheng Z, Mou S, Zhang B, Liu X, Zhang Q, Wang R, Li H, Zhang D, Zhao J. Circulating immune cell landscape and T-cell abnormalities in patients with Moyamoya disease. Clin Transl Med. 2024;(2024):e1647. https:\/\/doi.org\/10.1002\/ctm2.1647.","DOI":"10.1002\/ctm2.1647"},{"key":"4241_CR11","doi-asserted-by":"publisher","unstructured":"Zhu H, Chen J, Liu K, Gao L, Wu H, Ma L, Zhou J, Liu Z, Han JJ. Human PBMC scRNA-seq-based aging clocks reveal ribosome to inflammation balance as a single-cell aging hallmark and super longevity. Sci Adv. 2023;(2023):eabq7599. https:\/\/doi.org\/10.1126\/sciadv.abq7599.","DOI":"10.1126\/sciadv.abq7599"},{"key":"4241_CR12","doi-asserted-by":"publisher","unstructured":"Crnkovic S, Valzano F, Fliesser E, Gindlhuber J, Thekkekara PH, Basil M, Morley MP, Katzen J, Gschwandtner E, Klepetko W, Cantu E, Wolinski H, Olschewski H, Lindenmann J, Zhao YY, Morrisey EE, Marsh LM, Kwapiszewska G. Single-cell transcriptomics reveals skewed cellular communication and phenotypic shift in pulmonary artery remodeling. JCI Insight. 2022;(2022). https:\/\/doi.org\/10.1172\/jci.insight.153471.","DOI":"10.1172\/jci.insight.153471"},{"key":"4241_CR13","doi-asserted-by":"publisher","unstructured":"Bashore AC, Yan H, Xue C, Zhu LY, Kim E, Mawson T, Coronel J, Chung A, Sachs N, Ho S, Ross LS, Kissner M, Passegue E, Bauer RC, Maegdefessel L, Li M, Reilly MP. High-dimensional single-cell multimodal landscape of human carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2024;(2024):930\u2013945. https:\/\/doi.org\/10.1161\/ATVBAHA.123.320524.","DOI":"10.1161\/ATVBAHA.123.320524"},{"key":"4241_CR14","doi-asserted-by":"publisher","unstructured":"Kanamori F, Yokoyama K, Ota A, Yoshikawa K, Karnan S, Maruwaka M, Shimizu K, Ota S, Uda K, Araki Y, Okamoto S, Maesawa S, Wakabayashi T, Natsume A. Transcriptome-wide analysis of intracranial artery in patients with Moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair. Neurosurg Focus. 2021;(2021):E3. https:\/\/doi.org\/10.3171\/2021.6.FOCUS20870.","DOI":"10.3171\/2021.6.FOCUS20870"},{"key":"4241_CR15","doi-asserted-by":"publisher","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Rd Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R. Integrated analysis of multimodal single-cell data. Cell. 2021;(2021):3573\u20133587. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"4241_CR16","doi-asserted-by":"publisher","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;(2019):1289\u20131296. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","DOI":"10.1038\/s41592-019-0619-0"},{"key":"4241_CR17","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;(2015):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"key":"4241_CR18","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;(2019):1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","DOI":"10.1038\/s41467-019-09234-6"},{"key":"4241_CR19","doi-asserted-by":"publisher","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;(2012):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118.","DOI":"10.1089\/omi.2011.0118"},{"key":"4241_CR20","doi-asserted-by":"publisher","unstructured":"Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S, Seurinck R, Saelens W, Cannoodt R, Rouchon Q, Verbeiren T, De Maeyer D, Reumers J, Saeys Y, Aerts S. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;(2020):2247\u20132276. https:\/\/doi.org\/10.1038\/s41596-020-0336-2.","DOI":"10.1038\/s41596-020-0336-2"},{"key":"4241_CR21","doi-asserted-by":"publisher","unstructured":"Angerer P, Haghverdi L, Buttner M, Theis FJ, Marr C, Buettner F. Destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics. 2016;(2016):1241\u20131243. https:\/\/doi.org\/10.1093\/bioinformatics\/btv715.","DOI":"10.1093\/bioinformatics\/btv715"},{"key":"4241_CR22","doi-asserted-by":"publisher","unstructured":"Kang M, Armenteros JJA, Gulati GS, Gleyzer R, Avagyan S, Brown EL, Zhang W, Usmani A, Earland N, Wu Z, Zou J, Fields RC, Chen DY, Chaudhuri AA, Newman AM. Mapping single-cell developmental potential in health and disease with interpretable deep learning. bioRxiv. 2024;(2024). https:\/\/doi.org\/10.1101\/2024.03.19.585637.","DOI":"10.1101\/2024.03.19.585637"},{"key":"4241_CR23","doi-asserted-by":"publisher","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;(2017):979\u2013982. https:\/\/doi.org\/10.1038\/nmeth.4402.","DOI":"10.1038\/nmeth.4402"},{"key":"4241_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"2018","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N, Purdom E, Dudoit S. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018;2018:477. https:\/\/doi.org\/10.1186\/s12864-018-4772-0.","journal-title":"BMC Genomics"},{"key":"4241_CR25","doi-asserted-by":"publisher","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;(2021):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","DOI":"10.1038\/s41467-021-21246-9"},{"key":"4241_CR26","doi-asserted-by":"publisher","unstructured":"Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, Mundlos S, Vajkoczy P. The genetic basis of moyamoya disease. Transl Stroke Res. 2022;(2022):25\u201345. https:\/\/doi.org\/10.1007\/s12975-021-00940-2.","DOI":"10.1007\/s12975-021-00940-2"},{"key":"4241_CR27","doi-asserted-by":"publisher","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N. Homozygous c.14576G\u2009>\u2009A variant of RNF213 predicts early-onset and severe form of Moyamoya disease. Neurology. 2012;(2012):803\u2013810. https:\/\/doi.org\/10.1212\/WNL.0b013e318249f71f.","DOI":"10.1212\/WNL.0b013e318249f71f"},{"key":"4241_CR28","doi-asserted-by":"publisher","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW. Importance of RNF213 polymorphism on clinical features and long-term outcome in Moyamoya disease. J Neurosurg. 2016;(2016):1221\u20131227. https:\/\/doi.org\/10.3171\/2015.4.JNS142900.","DOI":"10.3171\/2015.4.JNS142900"},{"key":"4241_CR29","doi-asserted-by":"publisher","unstructured":"Chen T, Wei W, Yu J, Xu S, Zhang J, Li X, Chen J. The progression of pathophysiology of Moyamoya disease. Neurosurgery. 2023;(2023):502\u2013509. https:\/\/doi.org\/10.1227\/neu.0000000000002455.","DOI":"10.1227\/neu.0000000000002455"},{"key":"4241_CR30","doi-asserted-by":"publisher","unstructured":"Chen JB, Lei D, He M, Sun H, Liu Y, Zhang H, You C, Zhou LX. Clinical features and disease progression in Moyamoya disease patients with Graves disease. J Neurosurg. 2015;(2015):848\u2013855. https:\/\/doi.org\/10.3171\/2014.10.JNS141140.","DOI":"10.3171\/2014.10.JNS141140"},{"key":"4241_CR31","doi-asserted-by":"crossref","unstructured":"Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M, Ishikawa T, Ishimura E, Nishizawa Y. Increased stiffness in common carotid artery in hyperthyroid Graves\u2019 disease patients. Biomed Pharmacother. 2002;(2002):241\u2013246. https:\/\/pubmed.ncbi.nlm.nih.gov\/12199623\/.","DOI":"10.1016\/S0753-3322(02)00195-6"},{"key":"4241_CR32","doi-asserted-by":"publisher","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;(2022):939\u2013950. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009.","DOI":"10.1016\/j.molmed.2022.08.009"},{"key":"4241_CR33","doi-asserted-by":"publisher","unstructured":"Masuda J, Ogata J, Yutani C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in Moyamoya disease. Stroke. 1993;(1993):1960\u20131967. https:\/\/doi.org\/10.1161\/01.str.24.12.1960.","DOI":"10.1161\/01.str.24.12.1960"},{"key":"4241_CR34","doi-asserted-by":"publisher","unstructured":"Shirozu N, Ohgidani M, Hata N, Tanaka S, Inamine S, Sagata N, Kimura T, Inoue I, Arimura K, Nakamizo A, Nishimura A, Maehara N, Takagishi S, Iwaki K, Nakao T, Masuda K, Sakai Y, Mizoguchi M, Yoshimoto K, Kato TA. Angiogenic and inflammatory responses in human induced microglia-like (iMG) cells from patients with Moyamoya disease. Sci Rep. 2023;(2023):14842. https:\/\/doi.org\/10.1038\/s41598-023-41456-z.","DOI":"10.1038\/s41598-023-41456-z"},{"key":"4241_CR35","doi-asserted-by":"publisher","unstructured":"Miro-Mur F, Perez-de-Puig I, Ferrer-Ferrer M, Urra X, Justicia C, Chamorro A, Planas AM. Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation. Brain Behav Immun. 2016;(2016):18\u201333. https:\/\/doi.org\/10.1016\/j.bbi.2015.08.010.","DOI":"10.1016\/j.bbi.2015.08.010"},{"key":"4241_CR36","doi-asserted-by":"publisher","unstructured":"Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P, Wong SC. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;(2011):e16-e31. https:\/\/doi.org\/10.1182\/blood-2010-12-326355.","DOI":"10.1182\/blood-2010-12-326355"},{"key":"4241_CR37","doi-asserted-by":"publisher","unstructured":"Lee J, Tam H, Adler L, Ilstad-Minnihan A, Macaubas C, Mellins ED. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS One. 2017;(2017):e183594. https:\/\/doi.org\/10.1371\/journal.pone.0183594.","DOI":"10.1371\/journal.pone.0183594"},{"key":"4241_CR38","doi-asserted-by":"publisher","unstructured":"Liu C, Mou S, Zhang B, Pang Y, Chan L, Li J, He Q, Zheng Z, Zhao Z, Sun W, Shi X, Qiu H, Deng X, Wang W, Ge P, Zhao J. Innate immune cell profiling in peripheral blood mononuclear cells of patients with Moyamoya disease. Inflammation. 2024;(2024). https:\/\/doi.org\/10.1007\/s10753-024-02201-4.","DOI":"10.1007\/s10753-024-02201-4"},{"key":"4241_CR39","doi-asserted-by":"publisher","unstructured":"Lo SC, Lee WJ, Chen CY, Lee BC. Intermediate CD14(++)CD16(+) monocyte predicts severe coronary stenosis and extensive plaque involvement in asymptomatic individuals. Int J Cardiovasc Imaging. 2017;(2017):1223\u20131236. https:\/\/doi.org\/10.1007\/s10554-017-1097-z.","DOI":"10.1007\/s10554-017-1097-z"},{"key":"4241_CR40","doi-asserted-by":"publisher","unstructured":"Katayama K, Matsubara T, Fujiwara M, Koga M, Furukawa S. CD14\u2009+\u2009CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol. 2000;(2000):566\u2013570. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01321.x.","DOI":"10.1046\/j.1365-2249.2000.01321.x"},{"key":"4241_CR41","doi-asserted-by":"publisher","unstructured":"Jang JC, Li J, Gambini L, Batugedara HM, Sati S, Lazar MA, Fan L, Pellecchia M, Nair MG. Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction. Proc Natl Acad Sci U S A. 2017;(2017):E10399-E10408. https:\/\/doi.org\/10.1073\/pnas.1716015114.","DOI":"10.1073\/pnas.1716015114"},{"key":"4241_CR42","doi-asserted-by":"publisher","unstructured":"Rachwalik M, Hurkacz M, Sienkiewicz-Oleszkiewicz B, Jasinski M. Role of resistin in cardiovascular diseases: Implications for prevention and treatment. Adv Clin Exp Med. 2021;(2021):865\u2013874. https:\/\/doi.org\/10.17219\/acem\/135978.","DOI":"10.17219\/acem\/135978"},{"key":"4241_CR43","doi-asserted-by":"publisher","unstructured":"Yamamoto S, Yamamoto S, Akai T, Sasahara M, Kuroda S. Differentiation of fibroblasts into myofibroblasts in the arachnoid membrane of Moyamoya disease. Stroke. 2022;(2022):3465\u20133473. https:\/\/doi.org\/10.1161\/STROKEAHA.122.039961.","DOI":"10.1161\/STROKEAHA.122.039961"},{"key":"4241_CR44","doi-asserted-by":"publisher","unstructured":"Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, Baker AH. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;(2019):190\u2013209. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.089.","DOI":"10.1016\/j.jacc.2018.09.089"},{"key":"4241_CR45","doi-asserted-by":"publisher","unstructured":"Tang Q, Li W, Huang J, Wu Y, Ma C, Tu Y, Zhu Q, Lu J, Xie J, Liu Y, Mao X, Wu W. Single-cell sequencing analysis of peripheral blood in patients with Moyamoya disease. Orphanet J Rare Dis. 2023;(2023):174. https:\/\/doi.org\/10.1186\/s13023-023-02781-8.","DOI":"10.1186\/s13023-023-02781-8"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04241-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:23:45Z","timestamp":1773059025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04241-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4241"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04241-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6182457\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Nanchang University ((2023) CDYFYYLK(01\u2013021)). The blood samples were obtained with written informed consent from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors consent to the publication of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}